NASDAQ
PGEN
Last Price
US $5.12
KEY FIGURES
MKT CAP
$1.5B
EPS
TTM
$-0.65
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
50.74x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Precigen, Inc. cash flow to debt ratio of -89.36% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Precigen, Inc.'s free cash flow has decreased 17.03% from $-76.76M last year to $-89.83M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Precigen, Inc.'s debt to equity ratio is 4.86, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Precigen, Inc.'s debt has increased relative to shareholder equity from 0.14 last year to 4.86 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Precigen, Inc. has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
Precigen, Inc.'s interest coverage ratio is -13.86, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
Precigen, Inc.'s profit margin has increased (-79.88%) in the last year from -3.22K% to -646.99%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Precigen, Inc.'s short-term assets of $115.23M exceed its short-term liabilities of $37.31M
Decreasing performance - ROA.
Precigen, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Precigen, Inc.'s return on equity of -1.77K%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Precigen, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Precigen, Inc. had positive net income in only 1.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Precigen, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Precigen, Inc. has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Precigen, Inc.'s yearly earnings has decreased 98.55% since last year from $-126.23M to $-250.64M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Precigen, Inc.'s yearly revenue has increased 146.73% since last year from $3.92M to $9.68M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -79.18% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
Precigen, Inc.'s 3-year revenue CAGR of -28.87% is negative, indicating declining revenue over the past 3 years
Decreasing performance - Revenue consistency.
Precigen, Inc. had revenue growth in only 2.00 out of 5 years, indicating inconsistent revenue performance
Decreasing performance - ROE consistency.
Precigen, Inc. had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Precigen, Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Precigen, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Precigen, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Precigen, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Precigen, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
Precigen, Inc. has a price-to-book ratio of 79.13x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Overvalued - P/S ratio.
Precigen, Inc. has a price-to-sales ratio of 50.74x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-1768.51%
Return on equity
ROIC: -79.18%
Valuation History
-4.2X
Price to Earnings
EV/EBITDA: -8.7X
Cash flow
Profit margin
-21.26%
(FY vs FY)
EBITDA Y/Y
-22.53%
(FY vs FY)
Cash flow Y/Y
-1.20%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $5.12
—
Default assumptions
EBITDA Multiple
Fair Value
Market $5.12
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.